isomethyleugenol has been researched along with Minimal Disease, Residual in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado, Y; Boddu, P; Borthakur, G; Bose, P; Brandt, M; Cortes, J; Daver, N; DiNardo, CD; Garcia-Manero, G; Jabbour, EJ; Jorgensen, J; Kadia, T; Kantarjian, H; Konopleva, M; Naqvi, K; Pemmaraju, N; Pierce, S; Ravandi, F; Yilmaz, M | 1 |
| Bo, J; Dou, LP; Jing, Y; Li, HH; Sun, JF; Wang, QS; Wang, SH; Yu, L; Zhao, Y | 1 |
| Au, WY; Chan, CH; Chim, CS; Fung, AT; Kwong, YL; Liang, RH; Ma, ES; Wong, KF | 1 |
| Chim, CS; Kwong, YL; Liang, R; Tam, CY | 1 |
4 other study(ies) available for isomethyleugenol and Minimal Disease, Residual
| Article | Year |
|---|---|
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Recurrence; Risk | 2018 |
[Investigation on MS-PCR as a method for detecting minimal residual disease in acute leukemia].
Topics: HL-60 Cells; Humans; Inhibitor of Differentiation Proteins; Leukemia; Methylation; Neoplasm, Residual; Polymerase Chain Reaction | 2009 |
Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Humans; Leukemia, Promyelocytic, Acute; Methylation; Neoplasm, Residual; Oxides; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Genes, p16; Humans; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Sensitivity and Specificity; Transcription Factors; Transcriptional Activation; Tumor Suppressor Proteins | 2001 |